April 25, 2024
Office of Life Sciences
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
| Attention: | Daniel Crawford | |
| Re: | vTv Therapeutics Inc. Acceleration Request for Registration Statement on Form S-3 File No. 333-278612 | |
Dear Mr. Crawford,
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), vTv Therapeutics Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to April 29, 2024, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Dechert LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Dechert LLP, by calling David Rosenthal at (212) 698-3616.
If you have any questions regarding this request, please contact David Rosenthal of Dechert LLP at (212) 698-3616.
| Sincerely,
VTV THERAPEUTICS INC. |
| /s/ Steven Tuch |
| Steven Tuch Chief Financial Officer |
| cc: | David S. Rosenthal, Dechert LLP |